CHI-907 / Canopy Growth - LARVOL DELTA

CHI-907 CBD Extract and Experiences of Test Anxiety (clinicaltrials.gov) - P2; N=32; Terminated; Sponsor: Canopy Growth Corporation; N=200 ➔ 32; Trial completion date: Sep 2021 ➔ Jun 2021; Recruiting ➔ Terminated; Trial primary completion date: Sep 2021 ➔ Jun 2021; Recruitment challenges due to COVID

Clinical • Enrollment change • Trial completion date • Trial primary completion date • Trial termination • Mood Disorders • Psychiatry

CHI-907 CBD Extract and Experiences of Test Anxiety (clinicaltrials.gov) - P2; N=200; Recruiting; Sponsor: Canopy Growth Corporation; Trial completion date: Sep 2020 ➔ Sep 2021; Trial primary completion date: Sep 2020 ➔ Sep 2021

Clinical • Trial completion date • Trial primary completion date • Mood Disorders • Psychiatry

CHI-907 CBD Extract and Experiences of Test Anxiety (clinicaltrials.gov) - P2; N=200; Recruiting; Sponsor: Canopy Health Innovations

Clinical • New P2 trial